Fisher Wallace Campaign's Highlights
Medical Devices for Mood and Sleep
- Over 60,000 patients and 10,000 prescribers in the United States, with over $23.3M in lifetime revenue
Clear Path to FDA Approval
- Three clinical trials were submitted to the FDA on March 19, 2021 to support new approval and clearance; over-the-counter approval has been obtained in Europe, and Medicaid has approved the device in Maine (MaineCare)
Previous Crowdfunding Success
- Raised over $1M in an oversubscribed Reg CF raise from over 1400+ investors
Did I Invest In Fisher Wallace?
I’m still in the process of writing a full deal report and decide whether or not I will invest in Fisher Wallace. I review 100+ startups on 10+ platforms every month and send a detailed report every Saturday to subscribers of the Angel Notes newsletter (you can join through the form below). See you soon!